LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.

NEW YORK--(BUSINESS WIRE)--Estrella MediaCo is pleased to announce the promotions of two standout leaders as part of its continued investment in cross-platform growth and multicultural market leadership. Rogerio Alves has been promoted to Vice President, Digital Sales – CTV and Audio Streaming, where he will lead monetization strategies across Estrella's growing digital video and audio portfolio, including FAST channels, CTV, and streaming audio platforms. “Rogerio has been instrumental in shap.

President Trump raised global steel tariffs to 50% Friday, upsetting EU trade negotiators but benefitting US steel stocks.

Campbell's (CPB) came out with quarterly earnings of $0.73 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.75 per share a year ago.

LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bakkt Holdings, Inc. ("Bakkt" or "the Company") (NYSE: BKKT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 25, 2024 and March 17, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=151249&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

SAN DIEGO , June 2, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, both dates inclusive (the "Class Period"), have until July 28, 2025 to seek appointment as lead plaintiff of the UroGen class action lawsuit.

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) shares soared before Monday's opening bell after it announced it has inked a definitive agreement to merge with Beckley Psytech, a private clinical-stage biopharmaceutical company developing psychedelic-based therapies, in an all-share transaction valued at $390 million. The merger is contingent upon the achievement of pre-agreed success criteria in Beckley's ongoing Phase 2b trial of BPL-003 (mebufotenin benzoate), the company said.

WTKWY and ALX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2, 2025.

Signet Jewelers Limited SIG will release its first-quarter earnings results before the opening bell on Tuesday, June 3.

Merck's (NYSE:MRK) top-selling drug – Keytruda's – impressive recent growth tells a compelling story, but it's one with a predictable ending. The pharmaceutical giant's remarkable performance is largely attributed to the phenomenal success of Keytruda, its blockbuster oncology drug.

Peter Boockvar, Bleakley Advisory Group CIO, joins 'Squawk Box' to discuss the latest market trends ahead of the opening bell on Monday.

HOUSTON--(BUSINESS WIRE)--Innovex expands platform with acquisition of Citadel Casing Solutions.

CENTENNIAL, Colo.--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), a leader in high-power blue laser technology under a pivotal transformation plan, entered into a standby equity purchase agreement (the “Agreement”) with YA II PN, Ltd. (the “Investor”) under which the company has the option, subject to the conditions set forth therein, to sell up to $100 million in shares. This facility provides NUBURU with the financial flexibility to execute controlled stock sales until May 30, 2028. The.

Brent crude rose 1.8% to over $65 a barrel on Monday afternoon after OPEC+ confirmed it would maintain a gradual approach to increasing oil supply. The news also gave a lift to energy stocks, with shares in Shell PLC (LSE:SHEL, NYSE:SHEL) and BP PLC (LSE:BP.

CRL and CHDI Foundation extend their Huntington's disease partnership, boosting integration and global flexibility in drug discovery.

Monarch Casino delivered a strong Q1 FY2025, gaining market share despite flat or declining regional gaming revenues and temporary renovation disruptions. The company's pristine balance sheet, no long-term debt, and robust free cash flow support continued dividends and buybacks, enhancing total shareholder return. With a $95 price target, I see 13.5% upside; including dividends and buybacks, total return could reach 16–17%, justifying a continued 'Buy' rating.

Chinese car companies have surged ahead of Ford Motor Co. (NYSE: F) in EV sales.

Given the uncertain environment, I continue to accumulate Schwab U.S. Dividend Equity ETF™, balancing my AI optimism with a need for defensive positioning. The market's aggressive risk appetite overlooks ongoing macro uncertainties, making a defensive allocation like SCHD increasingly prudent. SCHD isn't immune to market panic and has notable exposure to volatile energy prices, but its dividend consistency remains a key strength.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151243&wire=1&utm_campaign=24 or contact Joseph E.